摘要 |
Disclosed are a compound represented by general formula I, a pharmaceutically-acceptable salt thereof, or an enantiomer, a diastereomer, a tautomer, a solvate, a polymorph or a prodrug thereof, and a preparation method therefor, and pharmaceutical uses thereof, wherein the groups are defined as in the specification. The compound of the present invention has good CDK kinase inhibition activity, and good development and application prospects. |
申请人 |
SHANGHAI INSTITUTE OF MATERIA MEDICA,CHINESE ACADEMY OF SCIENCES;SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. |
发明人 |
CAO, Jianhua;GENG, Meiyu;CHENG, Peng;HUANG, Min;JIANG, Lei;WANG, Huixin;LI, Lei;CHEN, Zhuxi;TANG, Shuai;SU, Yi;CAO, Wenjie;LIU, Lei;CHEN, Chunlin;DING, Jian |